Navigation Links
Concert Medical Launches 'Conductor™' Family of Interventional Coronary Guidewires
Date:7/14/2010

NORWELL, Mass., July 14 /PRNewswire/ -- Concert Medical, LLC today announced the launch of the "Conductor™" family of Interventional Coronary Guidewires to the U.S. market. These guidewires are designed to address an extensive range of coronary disease cases at a superior value. The FDA granted Concert Medical clearance for the use and sale in the U.S. of the Conductor product line in September 2009. Concert Medical is located in Norwell, Mass. and manufactures all of its interventional products in the United States.

Concert Medical is an integrated medical device manufacturer, directly controlling all design and critical manufacturing processes for its interventional products. This business integration ensures both product quality and greater value. Concert's Conductor guidewires offer enhanced trackability and crossability, with an increased reliable strength and superior torque response. Performance-enhancing design features include a proprietary hydrophilic coating to improve tactile feel and shaft markers at 90cm and 100cm for precise insertion measurement.

Howard Donnelly, President of Concert Medical, said the Conductor is the firm's second guidewire product released in 2010.  "Earlier this year we launched a private-labeled neurological guidewire, co-developed with a leading medical device company," noted Donnelly. "The Conductor, which we spent two years developing, is an outstanding addition to our interventional guidewire business."

Concert Medical, formerly The MicroSpring Company, was founded in 1982 as an exclusively contract manufacturer and was acquired by Donnelly and his partners in 2005. Since the acquisition, Donnelly has moved Concert from a contract manufacturer to a private label and proprietary medical device product developer.  "Whether it's for our own product line or private labeled for a customer, we add a lot of value to the design and manufacturing of medical products," noted Donnelly. "With close to 30 years of experience in the fields of Interventional Cardiology and Interventional Neurology, we have the knowledge, expertise, and resources to bring innovative products and updates to the marketplace."

Interventional Cardiologists interested in the Conductor can contact Emily O'Connor, Product Manager, at 781-871-7882, x151 or at emily.oconnor@concertmedical.com. For additional information on Concert Medical and its products, visit www.concertmedical.com.


'/>"/>
SOURCE Concert Medical, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson Says Appeals Court Affirms Concerta(R) Patent Invalid
2. CONCERTA(R) Patent Appeal Denied
3. CONCERTA(R) in the Classroom: New Data on Attention in Children With ADHD
4. Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients Day
5. New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
6. Varian Medical Systems to Showcase Fast, Precise Brachytherapy Planning System at Annual Meeting of American Association of Physicists in Medicine
7. Parkview Medical Center Selects MobileMD for Health Information Exchange Service
8. Medical Alarm Concepts™ Announces Roll-Out of the MediPendant™ at Albertsons
9. Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line
10. New White Paper Helps Medical Device Manufacturers Apply New FDA Regs to Combination Products
11. Crux Biomedical Named One of Top 50 Companies to Watch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 2017 Germany Cataract Surgery ... new report, "Germany Cataract Surgery Devices Market Outlook to ... Surgery Devices market. The report provides value, in millions ... (USD) within market segements - Phacoemulsification Equipment and Ophthalmic ... shares and distribution shares data for each of these ...
(Date:1/19/2017)... , Jan. 19, 2017 Report Details ... Devices Market? Which areas are going to grow at ... revenues to 2026, assessing data, trends, opportunities and prospects. ... graphs. Discover the most lucrative areas in the industry ... you assess forecasted sales across the all the major ...
(Date:1/19/2017)... , Jan. 19, 2017 The U.S. Food and ... Chronic Idiopathic Constipation (CIC) in adult patients. ... gastrointestinal disorders," said Julie Beitz , M.D., director of ... for Drug Evaluation and Research. "With the availability of new ... treatment for their condition." ...
Breaking Medicine Technology:
(Date:1/21/2017)... ... 21, 2017 , ... Pacifica Graduate Institute’s Alumni Association announced ... events for its annual meeting “Coming Home 2017,” an activity-packed weekend of educational ... will be held on Friday January 27 through Sunday, January 29, 2017 at ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel ... Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety of ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and ... essential oils, announced the company had a successful visit to the 2017 ECRM Diet, ... gives companies that work in the nutritional, sports and health industries a chance to ...
(Date:1/20/2017)... , ... January 20, 2017 , ... ... products to enhance people’s everyday lives, recently attended the January ECRM Trade Show ... ATP Science is known for its large range of supplements that keep the ...
(Date:1/20/2017)... New York, NY (PRWEB) , ... January 20, ... ... drinks – VW+ 001 and its sugar-free alternative VW+ 002. The drinks have ... the body with optimal conditions to perform during your workout. , After a ...
Breaking Medicine News(10 mins):